Bill G Kapogiannis
Affiliation: National Institutes of Health
- Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)Bill G Kapogiannis
Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Blvd, Bethesda, MD 20892 7510, USA
Clin Infect Dis 53:1024-34. 2011..The bimodal mortality distribution in HIV-infected children makes it important to evaluate temporal effects of HAART among a birth cohort with long-term, prospective follow-up...
- Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004)Bill G Kapogiannis
Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
Pediatrics 121:e1229-39. 2008..Highly active antiretroviral therapy has reduced rates of opportunistic infections; less is known about its effect on pediatric bacteremia rates. Thus, we sought to determine its impact on bacteremia incidence in HIV-infected children...
- Introduction: Paving the way for biomedical HIV prevention interventions in youthBill G Kapogiannis
Pediatric, Adolescent, and Maternal AIDS Branch, Center for Research for Mothers and Children, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
J Acquir Immune Defic Syndr 54:S1-4. 2010....
- Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004Steven R Nesheim
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
Pediatrics 120:100-9. 2007..We sought to determine the impact of highly active antiretroviral therapy on the incidence and prevalence of opportunistic infections in HIV-infected children...
- Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokinesSunil Kannanganat
Vaccine Research Center, Department of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, 954 Gatewood Road NE, Atlanta, GA 30329, USA
J Virol 81:12071-6. 2007..001) with viral load. These results demonstrate a strong association between the maintenance of highly functional CD4 T cells producing three cytokines and control of HIV-1...
- Comprehension of a simplified assent form in a vaccine trial for adolescentsSonia Lee
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Maternal Pediatric Infectious Disease Branch, Bethesda, Maryland, USA
J Med Ethics 39:410-2. 2013..A Hepatitis B vaccine trial with adolescents offers valuable opportunity to test youth understanding of vaccine trial requirements in general...
- Evidence-based programming for adolescent HIV prevention and care: operational research to inform best practicesBill G Kapogiannis
Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD and UNICEF, New York, NY
J Acquir Immune Defic Syndr 66:S228-35. 2014..Unique developmental, psychosocial, and environmental considerations make them particularly vulnerable to HIV acquisition and argue for a comprehensive response to address this burgeoning problem...
- Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammationSalma S Syed
Department of Pediatrics, SUNY at Stony Brook, Stony Brook, NY, USA
AIDS Res Hum Retroviruses 29:493-500. 2013..Only 9% of ART-treated subjects fully suppressed virus. Lipid profiles and hsCRP, traditional markers of cardiovascular disease, are not abnormal among HIV-infected youth but elevated sVCAM may be an early marker of atherosclerosis...
- Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohortBill G Kapogiannis
Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30329, USA
AIDS Res Hum Retroviruses 22:272-82. 2006..Longitudinal studies are clearly necessary to assess the impact of HAART on these parameters...
- Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trialsBret J Rudy
Department of Pediatrics, New York University School of Medicine, New York, NY, USA
J Acquir Immune Defic Syndr 54:S31-42. 2010..In this article, we will discuss issues around implementing each of these biomedical prevention modalities in trials among adolescents and young adults to help to guide future successful research targeting this population...
- Executive summary: opportunities for action and impact to address HIV and AIDS in adolescentsSusan Kasedde
HIV and AIDS Section, United Nations Children s Fund, New York, NY and Maternal and Pediatric Infectious Diseases Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD
J Acquir Immune Defic Syndr 66:S139-43. 2014..The global HIV epidemic in adolescents is not controlled, and this group has not received sufficient attention in programming and research efforts addressing HIV prevention, treatment, and care...
- Preexposure prophylaxis for adolescents and young adults at risk for HIV infection: is an ounce of prevention worth a pound of cure?Jill E Pace
Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 7510, USA
Clin Infect Dis 56:1149-55. 2013..YMSM and minority youth are at substantial HIV risk and urgently need effective HIV prevention tools for which the short and long-term benefits and risks have been carefully considered...
- An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infectionCherrie B Boyer
Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California San Francisco, 3333 California St, San Francisco, CA 94118, USA
JAMA Pediatr 167:289-96. 2013....
- Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccinationJessica A Kahn
Department of Pediatrics, Cincinnati Children s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA
J Acquir Immune Defic Syndr 61:390-9. 2012..The objectives of this study were to describe the prevalence and risk factors for HPV infection among HIV-infected young women receiving their first quadrivalent HPV (HPV-6, -11, -16, and -18) vaccine dose...
- Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infectionJennifer J Kiser
University of Colorado at Denver and Health Sciences Center, Denver, CO, USA
Antimicrob Agents Chemother 52:631-7. 2008..Additional studies of the exposure-response relationships of this regimen in children, adolescents, and adults would advance our knowledge of its pharmacodynamic properties...
- Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions studyRolando M Viani
University of California, San Diego School of Medicine, San Diego, La Jolla, CA 92093 0672, USA
J Infect Dis 194:1505-9. 2006..5%) for PIs. The prevalence of primary HIV-1 drug resistance, particularly to NNRTIs, in this group of recently infected youth was high...